SER
Serina Therapeutics, Inc.
US
Aug 27, 2026, 00:00 UTC
Serina Therapeutics entered into a Common Stock Purchase Agreement with Roth Principal Investments, granting Serina the right to sell up to $25,000,000 of newly issued common stock over a 36-month period, and agreed to file a registration statement for the resale of those shares.